Latest News for: mg tokyo

Edit

Studies Support Use of Daily Antibiotic to Prevent STDs in High-Risk Groups

Atlantic News Telegraph 19 Jul 2024
The study tracked outcomes for 40 female sex workers in Tokyo. All were provided with daily 100 mg doses of doxycycline and followed over time ... As to side effects, 22.7% of participants in the Tokyo ...
Edit

Dr Chris Brown reveals the moment he

The Daily Mail 31 Jan 2024
Dr Chris Brown has revealed the embarrassing moment he 'wet himself' on a train in Tokyo. The celebrity vet, 45, made the admission during an interview on Triple M's Mick and MG in the Morning on Wednesday.
Edit

ENHERTU® Demonstrated Strong and Durable Tumor Responses in Previously Treated HER2 Mutant Advanced Lung Cancer in DESTINY-Lung02 Phase 2 Trial

Pharmiweb 11 Sep 2023
39.0-59.1) in the 5.4 mg/kg arm and 56.0% (95% CI. 41.3-70.0) in the 6.4 mg/kg arm was observed as assessed by blinded independent central review (BICR) ... 86.4-97.2) at the 5.4 mg/kg dose and 92.0% (95% CI. 80.8-97.8) at the 6.4 mg/kg dose.
Edit

TNL Mediagene, a leading Asian digital-media company, agrees to become publicly listed company on Nasdaq ...

Victoria Advocate 06 Jun 2023
(TNL), which through rapid growth and strategic acquisitions over the last decade has become a leading independent, pan-Asian digital-media group, and Tokyo-based Mediagene Inc ... 25 years ago in Tokyo with co-founder Hiroto Kobayashi.
Edit

Japanese PM visits Bucha ahead of Zelenskyy meeting on surprise Ukraine trip

La Prensa Latina 21 Mar 2023
The Japanese leader’s visit to Ukraine coincides with that of regional rival China’s Xi Jinping to Moscow, which Tokyo has said it would closely watch. EFE. mg/ks Tags ....
Edit

Review on the origin of Type Ia supernovae

Phys Dot Org 30 Jan 2023
Ken'ichi Nomoto, Professor Emeritus of The University of Tokyo, in the proceedings of The Sixteenth Marcel Grossmann Meeting on General Relativity. The MG meeting is a tri-annual event, founded in 1975 ...
Edit

Astellas Announces Topline Results From Phase 3 Long-Term Safety Study Of Fezolinetant In Mainland China'

MENA FN 05 Sep 2022
(MENAFN - PR Newswire) Clinical trial evaluated the safety and tolerability of 30 mg dose for the treatment of vasomotor symptoms (VMS) associated with menopause TOKYO, Sept. 4, 2022 /PRNewswire/ ... .
  • 1

Most Viewed

×